The IFM 2012-03 trial: what will the next step be?
How to manage infections after hematopoietic stem cell transplantation and the issue of resistance
How the treatment of ALL is changing
How durable are the responses of CLL patients to therapy?
Curative strategy for smoldering multiple myeloma: GEM-CESAR